ArticleHemato2024
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax.
Alexandria P Eiken et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleHemato2024
Alexandria P Eiken et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.